Antinociceptive and anti-rheumatoidal effects of Kalopanax pictus extract and its saponin components in experimental animals

被引:75
作者
Choi, J
Huh, K
Kim, SH
Lee, KT
Park, HJ [1 ]
Han, YN
机构
[1] Sangji Univ, Div Appl Plant Sci, Wonju 220702, South Korea
[2] Seoul Natl Univ, Inst Nat Prod Res, Seoul 110460, South Korea
[3] Kyungsung Univ, Coll Pharm, Pusan 608736, South Korea
[4] Yeungnam Univ, Coll Pharm, Kyongsan 712749, South Korea
[5] Dong A Univ, Dept Food Sci & Nutr, Pusan 604714, South Korea
[6] Kyung Hee Univ, Coll Pharm, Seoul 130701, South Korea
关键词
Kalopanax pictus; kalopanaxsaponin; rheumatoidal arthritis; Freund's adjuvant reagent; antinociceptive; LD50;
D O I
10.1016/S0378-8741(01)00383-X
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
In the present study, we have attempted to elucidate the active components for rheumatoidal arthritis using chloroform (CHCl3), ethylacetate (EtOAc) and n-butanol (BuOH) fractions of the methanol extract (MeOH) of Kalopanax pictus. Kalopanaxsaponin-A and -I (KPS-A and -I, hederagenin monodesmoside) were isolated from EtOAc fraction and kalopanaxsaponin-B, -H and -K (KPS-B, -H and -K, hederagenin bisdesmosides) obtained from BuOH fraction, respectively. MeOH extract, EtOAc fraction (250, 500 mg/kg, p.o.) and KPS-A and -I (5, 10, 20 mg/kg, i.p.) exhibited significant antinociceptive effects, which were determined by acetic acid-induced writhing test and hot plate test. On Freund's complete adjuvant reagent-induced rheumatoidal arthritis in rats, the administration of EtOAc fraction and KPS-A and -I inhibited edema, agglutination, vascular permeability and trypsin inhibitor. In addition, LD50 of the MeOH extract was shown to be 4.033 mg/kg. These results sua est that anti-rheumatoidal effects of K-PS-A and -I contribute to the inhibition of kinin formation by suppression of trypsin inhibitor activity. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 16 条
[1]  
BIETH J, 1969, CLIN CHIM ACTA, V20, P69
[2]  
FRITZ H, 1965, Z PHYSL CHEM, V342, P253
[3]  
JU WK, 1993, LAB PHARM TOXICOLOGY, P53
[4]  
Kim DH, 1998, BIOL PHARM BULL, V21, P360
[5]   Growth inhibitory activities of kalopanaxsaponins A and I against human pathogenic fungi [J].
Kim, DW ;
Bang, KH ;
Rhee, YH ;
Lee, KT ;
Park, HJ .
ARCHIVES OF PHARMACAL RESEARCH, 1998, 21 (06) :688-691
[6]  
KIM SI, 1984, TEST CLIN PATHOLOGY, P38
[7]  
Kim T., 1996, KOREAN RESOURCES PLA, P169
[8]   Essential moiety for antimutagenic and cytotoxic activity of hederagenin monodesmosides and bisdesmosides isolated from the stem bark of Kalopanax pictus [J].
Lee, KT ;
Sohn, IC ;
Park, HJ ;
Kim, DW ;
Jung, GO ;
Park, KY .
PLANTA MEDICA, 2000, 66 (04) :329-332
[9]  
Lee M. W., 1991, ARCH PHARM RES, V14, P124
[10]   PROTEINASE-INHIBITORS SUPPRESS THE FORMATION OF GRANULATION-TISSUE IN THE CARRAGEENIN-INDUCED INFLAMMATION IN RATS [J].
NAKAGAWA, H ;
SHUTO, K ;
ISAJI, M ;
WATANABE, K ;
TSURUFUJI, S .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1981, 4 (06) :429-435